ArticleNeurology and therapy2026
Patient Perceptions of Needs and Expectations Regarding the Current Management of Myasthenia Gravis: A Biopsychosocial Study.
Article in Neurology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionInformation on the biopsychosocial needs and healthcare experiences of people living with myasthenia gravis (PwMG) in Spain remains limited. This study aimed to describe self-reported experiences and provide an overview of the condition's physical, psychological, and social impact.
methodsA multicenter cross-sectional epidemiological study was conducted through a nationwide online survey completed by a geographically stratified sample of PwMG across 13 of Spain's 17 Autonomous Communities.
resultsA total of 208 valid responses were analyzed (mean age 58.8; SD 15.2 years; range 16-94; 55.8% men). Nearly half (49.5%) reported generalized myasthenia gravis (MG), and 36.4% held a disability certificate. Although most respondents perceived their health as good or very good (45.2%), pain or discomfort affected 51.5%, and half reported emotional symptoms such as anxiety or depression. The mean EQ-VAS score was 66.1 (SD 20.6), reflecting a reduced health-related quality of life (HRQoL) compared with the general population. While satisfaction with access to and quality of medical care was generally high, many patients expressed concerns about limited psychological support and insufficient social care for themselves and their caregivers.
conclusionPwMG in Spain generally perceive their health positively, but significant unmet needs persist in psychological care and social protection. These findings underscore the importance of comprehensive patient-centered strategies that integrate medical, emotional, and social support to improve quality of life in MG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.